Publications

ORCID: 0000-0001-5827-6382

peer-reviewed publications

Simoes, F.A.*, Joilin, G.*, Peters, O., Schneider, L.-S., Priller, J., Spruth, E.J., Vogt, I., Kimmich, O., Spottke, A., Hoffmann, D.C., Falkenburger, B., Brandt, M., Prudlo, J., Brockmann, K., Fries, F.L., Rowe, J.B., Church, A., Respondek, G., Newbury, S.F., Leigh, P.N., Morris, H.R., Höglinger, G.U., Hafezparast, M. (2022). Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy. International Journal of Molecular Sciences, 23.

*co-first authors

https://doi.org/10.3390/ijms232314554

Joilin, G., Gray, E., Thompson, A.G., Talbot, K., Leigh, P.N., Newbury, S., Turner, M.R., & Hafezparast, M. (2022). Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Annals of Medicine, 54, 1.

https://doi.org/10.1080/07853890.2022.2138530

Joilin, G., Gray, E., Thompson, A.G., Bobeva, Y., Talbot, K., Weishaupt, J., Ludolph, A., Malaspina, A., Leigh, P.N., Newbury, S., Turner, M.R., & Hafezparast, M. (2020). Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosis. Brain Communications, 2, 1.

https://doi.org/10.1093/braincomms/fcaa053

Christoforidou, E., Joilin, G., & Hafezparast, M. (2020). Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis. Journal of Neuroinflammation, 17, 135.

https://doi.org/10.1186/s12974-020-01822-4

Joilin, G., Leigh, P.N., Newbury, S.F., & Hafezparast, M. (2019). An Overview of MicroRNAs as Biomarkers of ALS. Frontiers in Neurology. 10:186.

https://doi.org/10.3389/fneur.2019.00186

Joilin, G. (2015). The Role of microRNA in the Persistence of Long-Term Potentiation In Vivo (Thesis, Doctor of Philosophy). University of Otago.

http://hdl.handle.net/10523/6043

Ryan, B., Joilin, G., & Williams, J.M. (2015). Plasticity-related microRNA and their potential contribution to the maintenance of long-term potentiation. Frontiers in Molecular Neuroscience, 8, 4.

https://doi.org/10.3389/fnmol.2015.00004

Joilin, G., Guevremont, D., Ryan, B., Claudianos, C., Cristino, A.S., Abraham, W. C., & Williams, J.M. (2014). Rapid regulation of microRNA following induction of long-term potentiation in vivo. Frontiers in Molecular Neuroscience, 7, 98.

https://doi.org/10.3389/fnmol.2014.00098

conference proceedings

Joilin, G., Kirby, J., Shaw, P. J., Hafezparast, M. (2022). Identification of ncRNA biomarkers in longitudinal serum samples from people with ALS. Oral presented at the non-coding RNA in ALS mini-symposium at the European Network to Cure ALS (ENCALS) 2022 in Edinburgh, United Kingdom.

Joilin, G., Gray, E., Thompson, A. G., Talbot, K., Leigh, P. N., Newbury, S., Turner, M. R., & Hafezparast, M. (2022). Profiling of non-coding RNA as biomarkers in cerebrospinal fluid of amyotrophic lateral sclerosis patients. Poster presented at the European Network to Cure ALS (ENCALS) 2022 in Edinburgh, United Kingdom.

Joilin, G., Gray, E., Thompson, A. G., Bobeva, Y., Talbot, K., Weishaupt, J., Ludolph, A., Malaspina, A., Leigh, P. N., Newbury, S., Turner, M. R., & Hafezparast, M. (2020). Cross-site validation of the diagnostic accuracy of a ncRNA biomarker panel in ALS. Poster presented at the 31st Virtual International Symposium on MND/ALS.

Joilin, G., Gray, E., Thompson, A. G., Bobeva, Y., Talbot, K., Ludolph, A., Malaspina, A., Leigh, P. N., Newbury, S., Turner, M. R., & Hafezparast, M. (2020). Cross-site validation of the diagnostic accuracy of a ncRNA biomarker panel in amyotrophic lateral sclerosis (ALS). Poster presented at RNA 2020.

Joilin, G., Gray, E., Thompson, A. G., Bobeva, Y., Talbot, K., Ludolph, A., Malaspina, A., Leigh, P. N., Newbury, S., Turner, M. R., & Hafezparast, M. (2019). Identification of a non-coding RNA biomarker signature from serum in amyotrophic lateral sclerosis (ALS). Poster presented at The Non-Coding Genome - EMBO | EMBL Symposia in Heidelberg, Germany.

Joilin, G., Gray, E., Thompson, A. G., Talbot, K., Turner, M. R., Newbury, S., Leigh, P. N., & Hafezparast, M. (2018). Identification of a non-coding RNA biomarker signature from serum in ALS. Oral presented at the 2019 South Coast RNA Meeting in Canterbury, United Kingdom.

Joilin, G., Gray, E., Thompson, A. G., Talbot, K., Turner, M. R., Newbury, S., Leigh, P. N., & Hafezparast, M. (2018). Identification of a non-coding RNA biomarker signature from serum in ALS. Oral presented at the 29^th International Symposium on MND/ALS in Glasgow, United Kingdom.

Joilin, G., Gray, E., Thompson, A. G., Talbot, K., Turner, M. R., Newbury, S., Leigh, P. N., & Hafezparast, M. (2018). Non-coding RNA serum biomarkers in ALS. Oral presented at the European Network to Cure ALS (ENCALS) 2018 in Oxford, United Kingdom.

Joilin, G., Guevremont, D., Abraham, W. C., Print, C., Claudianos, C., & Williams, J. M. (2014). Bioinfomatic identification of genes targeted by microRNA regulated following induction of long-term potentiation in vivo. Poster presented at Neuroscience 2014 in Washington D.C., United States of America.

Joilin, G., Guévremont, D., Ryan, B., Logan, B., Abraham, W.C., & Williams, J.M. (2012). N-Methyl-D-Aspartic acid receptor-specific down-regulation of mature microRNA, miR-34a, following induction of long-term potentiation in vivo. Oral presented at the Non-Coding RNA Queenstown Molecular Biology satellite, Queenstown, New Zealand.

Joilin, G., Guévremont, D., Ryan, B., Logan, B., Abraham, W.C., & Williams, J.M. (2012). N-Methyl-D-Aspartic acid receptor-specific down-regulation of mature microRNA, miR-34a, following induction of long-term potentiation in vivo. Poster presented at the Australasian Winter Conference on Brain Research, Queenstown, New Zealand.

SEMINARS

Regulating Time Travel: The Story of Long-Term Potentiation, microRNA, and “Bioinformatics”. Seminar presented to the Department of Anatomy, University of Otago, Dunedin, New Zealand in November 2014.